ACST | Acasti Pharma Inc.

Index- P/E- EPS (ttm)-0.41 Insider Own- Shs Outstand44.61M Perf Week1.38%
Market Cap23.91M Forward P/E- EPS next Y-0.46 Insider Trans- Shs Float35.46M Perf Month19.96%
Income-17.20M PEG- EPS next Q-0.14 Inst Own0.08% Short Float / Ratio1.47% / 8.78 Perf Quarter9.41%
Sales- P/S- EPS this Y79.90% Inst Trans- Short Interest0.52M Perf Half Y28.27%
Book/sh2.17 P/B0.25 EPS next Y-6.30% ROA-14.00% Target Price2.00 Perf Year-45.69%
Cash/sh0.70 P/C0.77 EPS next 5Y- ROE-16.80% 52W Range0.34 - 1.05 Perf YTD7.23%
Dividend- P/FCF- EPS past 5Y49.50% ROI- 52W High-48.84% Beta1.52
Dividend %- Quick Ratio9.70 Sales past 5Y- Gross Margin- 52W Low58.00% ATR0.03
Employees32 Current Ratio9.70 Sales Q/Q- Oper. Margin- RSI (14)61.65 Volatility5.86% 5.54%
OptionableNo Debt/Eq0.00 EPS Q/Q-2.20% Profit Margin- Rel Volume1.02 Prev Close0.53
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume59.15K Price0.54
Recom1.00 SMA207.67% SMA5013.57% SMA200-5.48% Volume60,338 Change0.43%
Date Action Analyst Rating Change Price Target Change
Sep-01-20Downgrade Oppenheimer Outperform → Perform
Jul-06-20Upgrade B. Riley FBR Neutral → Buy $2
Jan-13-20Downgrade B. Riley FBR Buy → Neutral
Aug-29-19Initiated B. Riley FBR Buy $7.75
Jul-18-19Initiated Oppenheimer Outperform $7
Jun-26-19Initiated H.C. Wainwright Buy $6
May-17-23 09:00AM
May-10-23 07:41AM
May-08-23 07:00AM
Apr-04-23 08:01AM
08:30AM Loading…
Mar-30-23 08:30AM
Mar-13-23 08:00AM
Mar-08-23 09:00AM
Mar-04-23 08:28AM
Feb-28-23 01:00PM
Feb-15-23 04:02PM
Feb-14-23 07:00AM
Feb-07-23 09:00AM
09:00AM Loading…
Jan-25-23 09:00AM
Jan-24-23 04:15PM
Jan-17-23 10:00AM
Jan-13-23 09:00AM
Jan-05-23 09:00AM
Dec-29-22 06:02AM
Dec-28-22 08:00AM
Dec-22-22 08:00AM
Nov-14-22 07:00AM
Nov-09-22 04:15PM
Nov-07-22 04:15PM
Sep-30-22 09:00AM
Sep-29-22 09:00AM
Sep-21-22 08:45AM
04:15PM Loading…
Sep-14-22 04:15PM
Sep-13-22 08:00AM
Sep-12-22 09:00AM
Aug-11-22 01:00PM
Aug-02-22 04:15PM
Jul-27-22 08:00AM
Jul-07-22 08:55AM
Jun-22-22 06:10PM
Jun-21-22 08:00AM
Jun-16-22 04:15PM
Jun-14-22 08:00AM
May-23-22 04:15PM
May-18-22 11:20AM
May-16-22 01:30PM
May-12-22 08:00AM
May-06-22 09:02AM
Apr-25-22 08:30AM
Mar-25-22 07:30AM
Mar-22-22 07:30AM
Mar-09-22 08:30AM
Feb-28-22 08:30AM
Feb-23-22 09:50AM
Feb-22-22 09:09AM
Feb-14-22 07:00AM
Feb-07-22 08:30AM
Jan-03-22 08:30AM
Dec-23-21 10:49AM
Dec-22-21 03:40PM
Dec-21-21 04:57AM
Dec-02-21 07:00AM
Nov-24-21 08:30AM
Nov-12-21 05:34PM
Nov-11-21 08:30AM
Nov-10-21 07:00AM
Nov-04-21 08:30AM
Oct-07-21 10:15AM
Oct-06-21 08:30AM
Sep-27-21 08:30AM
Sep-22-21 08:30AM
Sep-14-21 08:30AM
Sep-08-21 08:30AM
Aug-31-21 02:27PM
Aug-27-21 08:40AM
Aug-25-21 07:02AM
Aug-12-21 07:00AM
Jul-29-21 08:30AM
Jul-23-21 08:30AM
Jul-07-21 09:00AM
Jul-06-21 11:02AM
Jul-03-21 06:52PM
Jun-24-21 03:22AM
Jun-23-21 08:27AM
Jun-22-21 07:00AM
Jun-14-21 04:20PM
May-17-21 07:00AM
May-13-21 06:05PM
May-12-21 05:31PM
May-07-21 11:53AM
Mar-08-21 05:30PM
Feb-09-21 06:55AM
Jan-27-21 06:55AM
Dec-25-20 12:00PM
Dec-23-20 03:24PM
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.